Erythropoietin’s inhibiting impact on hepcidin expression occurs indirectly

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 308, Issue 4, 2015, Pages R330-R335

  Gammella, Elena ^a   Diaz, Victor ^b   Recalcati, Stefania ^a   Buratti, Paolo ^a   Samaja, Michele ^c   Dey, Soumyadeep ^d   Noguchi, Constance Tom ^d   Gassmann, Max ^b,e   Cairo, Gaetano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF MILAN   (Italy)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Bone morphogenetic protein 6; Erythropoietin receptor; Ferroportin; Iron; Liver

Indexed keywords

ARA290 PEPTIDE; CARBAMYLATED ERYTHROPOIETIN; ERYTHROFERRONE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; FERRITIN; FERROPORTIN; HEPCIDIN; HETERODIMER; IRON; MESSENGER RNA; PEPTIDE HORMONE ANTAGONIST; PROTEIN SYNTHESIS INHIBITOR; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; CTRP15 PROTEIN, MOUSE; CYTOKINE; MUSCLE PROTEIN; OLIGOPEPTIDE; PYROGLUTAMATE HELIX B SURFACE PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C1C7 CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MEGADOSE; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; HEPATOCELLULAR CARCINOMA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IRON BALANCE; IRON KINETICS; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM; REPEATED DRUG DOSE; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DEFICIENCY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECTS; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; KNOCKOUT MOUSE; LIVER; METABOLISM; TIME FACTOR;

ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ERYTHROPOIETIN; HEP G2 CELLS; HEPCIDINS; HUMANS; IRON; LIVER; MALE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; MUSCLE PROTEINS; OLIGOPEPTIDES; RECEPTORS, ERYTHROPOIETIN; RNA, MESSENGER; TIME FACTORS;

EID: 84923176656     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00410.2014     Document Type: Article

References (23)

1. Brines M, Cerami A. Discovering erythropoietin’s extra-hematopoietic functions: biology and clinical promise. Kidney Int 70: 246–250, 2006.
2. Camaschella C, Pagani A. Iron and erythropoiesis: a dual relationship. Int J Hematol 93: 21–26, 2011.
3. Díaz V, Gammella E, Recalcati S, Santambrogio P, Naldi AM, Vogel J, Gassmann M, Cairo G. Liver iron modulates hepcidin expression during chronically elevated erythropoiesis in mice. Hepatology 58: 2122–2132, 2013.
4. Fein E, Merle U, Ehehalt R, Herrmann T, Kulaksiz H. Regulation of hepcidin in HepG2 and RINm5F cells. Peptides 28: 951–957, 2007.
5. Gassmann M, Grenacher B, Rohde B, Vogel J. Quantifying Western blots: pitfalls of densitometry. Electrophoresis 30: 1845–1855, 2009.
6. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell 142: 24–38, 2010.
7. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 46: 678–684, 2014.
8. Kautz L, Nemeth E. Molecular liaisons between erythropoiesis and iron metabolism. Blood 124: 479–482, 2014.
9. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami- Hand C, Xie QW, Coleman T, Cerami A, Brines M. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239–242, 2004.
10. Mastrogiannaki M, Matak P, Mathieu JR, Delga S, Mayeux P, Vaulont S, Peyssonnaux C. Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis. Haematologica 97: 827–834, 2012.
11. Meynard D, Babitt JL, Lin HY. The liver: conductor of systemic iron balance. Blood 123: 168–176, 2014.
12. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110: 1037–1044, 2002.
13. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108: 3730–3735, 2006.
14. Pinto JP, Ribeiro S, Pontes H, Thowfeequ S, Tosh D, Carvalho F, Porto G. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBP. Blood 111: 5727–5733, 2008.
15. Sasaki Y, Noguchi-Sasaki M, Yasuno H, Yorozu K, Shimonaka Y. Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice. Int J Hematol 96: 692–700, 2012.
16. Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood 116: 3627–3634, 2010.
17. Sonnweber T, Nachbaur D, Schroll A, Nairz M, Seifert M, Demetz E, Haschka D, Mitterstiller AM, Kleinsasser A, Burtscher M, Trübsbach S, Murphy AT, Wroblewski V, Witcher DR, Mleczko-Sanecka K, Vecchi C, Muckenthaler MU, Pietrangelo A, Theurl I, Weiss G. Hypoxia induced downregulation of hepcidin is mediated by plateletderived growth factor BB. Gut 63: 1951–1959, 2014.
18. Suzuki N, Ohneda O, Takahashi S, Higuchi M, Mukai HY, Nakahata T, Imagawa S, Yamamoto M. Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood 100: 2279–2288, 2002.
19. Swartjes M, Morariu A, Niesters M, Brines M, Cerami A, Aarts L, Dahan A. ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain: an experimental study in rats and β-common receptor knockout mice. Anesthesiology 115: 1084–1092, 2011.
20. Vecchi C, Montosi G, Garuti C, Corradini E, Sabelli M, Canali S, Pietrangelo A. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. Gastroenterology 146: 1060–1069, 2014.
21. Vecchi C, Montosi G, Zhang K, Lamberti I, Duncan SA, Kaufman RJ, Pietrangelo A. ER stress controls iron metabolism through induction of hepcidin. Science 325: 877–880, 2009.
22. Vogel J, Gassmann M. Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models. J Physiol 589: 1259–1264, 2011.
23. Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 55: 667–674, 2006.